Who has invested in Leadsynbio?

Lilly Asia Ventures, Sherpa Healthcare Partners are named among the investors backing Leadsynbio.

Leadsynbio Funding: $5.3M Raised, Series D (2023)

Leadsynbio funding overview

Leadsynbio is based in Suzhou, Jiangsu, China. Leadsynbio has raised $5.3M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series D announced in July 2023. The round record for Leadsynbio runs through 2023; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, Sherpa Healthcare Partners. 2 distinct backers are named across the disclosed rounds.

Leadsynbio at a glance

Total raised: $5.3M
Latest round: Series D
Latest round date: July 2023
Headquarters: Suzhou, Jiangsu, China
Notable investors: Lilly Asia Ventures, Sherpa Healthcare Partners

Frequently asked about Leadsynbio funding

How much has Leadsynbio raised?: Leadsynbio has raised $5.3M in total disclosed funding across the rounds on record.
Who has invested in Leadsynbio?: Lilly Asia Ventures, Sherpa Healthcare Partners are named among the investors backing Leadsynbio.
What was the latest Leadsynbio funding round?: The most recent disclosed round is a Series D, announced in July 2023.
Where is Leadsynbio based?: Leadsynbio is based in Suzhou, Jiangsu, China.
When did Leadsynbio last raise?: The last disclosed Leadsynbio round closed in July 2023 at Series D.

Totals shown for Leadsynbio aggregate every disclosed round on file. To see how that compares, browse the companies in Suzhou and the investors behind them below.

Leadsynbio Funding: $5.3M Raised, Series D (2023)

Leadsynbio funding overview

Leadsynbio at a glance

Frequently asked about Leadsynbio funding

Companies related to Leadsynbio (34)

Browse related funding lists (5)